FullHope Biomedical Co (ROCO:7773) Loans Receivable: NT$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7773 FullHope Biomedical Co Ltd ROCO:7773
15 GF Score
Price NT$26.00
! 1 Warning Sign
View Full Analysis

What is FullHope Biomedical Co Loans Receivable?

FullHope Biomedical Co ROCO:7773 +2.16% 15 Loans Receivable is NT$0.00 Mil as of Jun. 2026. GuruFocus rates ROCO:7773 with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

FullHope Biomedical Co's Loans Receivable for the quarter that ended in Jun. 2026 was NT$0.00 Mil.


FullHope Biomedical Co Loans Receivable Related Terms


FullHope Biomedical Co Loans Receivable Historical Data

* Premium members only.

The historical data trend for FullHope Biomedical Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FullHope Biomedical Co Loans Receivable Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
0.00 0.00 0.00 0.00 0.00

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:7773
15GF Score
FullHope Biomedical Co Ltd ROCO:7773
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FullHope Biomedical Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of NT$0.00 Mil mean?
FullHope Biomedical Co (ROCO:7773) has a Loans Receivable of NT$0.00 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on FullHope Biomedical Co and its competitors.
Is FullHope Biomedical Co's Loans Receivable too high?
FullHope Biomedical Co's current Loans Receivable is NT$0.00 Mil. Overall, FullHope Biomedical Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's Loans Receivable compare to VRTX and REGN?
FullHope Biomedical Co's Loans Receivable of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Biotechnology company?
A good Loans Receivable depends on the Biotechnology industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on FullHope Biomedical Co and its competitors. FullHope Biomedical Co's current Loans Receivable is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current Loans Receivable of NT$0.00 Mil. The current Loans Receivable is NT$0.00 Mil. FullHope Biomedical Co's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current Loans Receivable is NT$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FullHope Biomedical Co Business Description

Address Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
15GF Score

Get the complete analysis for ROCO:7773

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.00
Price